Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer.
Oudard S, Banu E, Beuzeboc P, Voog E, Dourthe LM, Hardy-Bessard AC, Linassier C, Scotté F, Banu A, Coscas Y, Guinet F, Poupon MF, Andrieu JM. Oudard S, et al. Among authors: coscas y. J Clin Oncol. 2005 May 20;23(15):3343-51. doi: 10.1200/JCO.2005.12.187. Epub 2005 Feb 28. J Clin Oncol. 2005. PMID: 15738542 Clinical Trial.
[Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM, Casassus P, Coscas Y, Darmont J, Goubeau C, Katz M, Jacquillat C, Tricot G, Weil M. Andrieu JM, et al. Among authors: coscas y. Bull Cancer. 1982;69(4):321-9. Bull Cancer. 1982. PMID: 6897520 Clinical Trial. French. No abstract available.
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC, Lipinski F, Schraub S, Maulard-Durdux C, Bensadoun RJ, Ardiet JM, Bolla M, Coscas Y, Baillet F, Coche-Dequéant B, Urbajtel M, Montbarbon X, Bourdin S, Wibault M, Alfonsi M, Calais G, Desprez P, Pene F, Lapeyre M, Vinke J, Maral J. Horiot JC, et al. Among authors: coscas y. Radiother Oncol. 2000 Jun;55(3):233-9. doi: 10.1016/s0167-8140(99)00018-3. Radiother Oncol. 2000. PMID: 11041775 Clinical Trial.
Prostate cancer screening: contrasting trends.
Eisinger F, Morère JF, Touboul C, Pivot X, Coscas Y, Blay JY, Lhomel C, Viguier J. Eisinger F, et al. Among authors: coscas y. Cancer Causes Control. 2015 Jun;26(6):949-52. doi: 10.1007/s10552-015-0573-9. Epub 2015 Mar 31. Cancer Causes Control. 2015. PMID: 25822574
Screening for prostate cancer: growth without control.
Eisinger F, Blay JY, Pivot X, Morère JF, Coscas Y, Calazel-Benque A, Roussel C, Viguier J. Eisinger F, et al. Among authors: coscas y. Eur J Cancer Prev. 2011 Jan;20 Suppl 1:S33-5. doi: 10.1097/01.cej.0000391568.26136.bc. Eur J Cancer Prev. 2011. PMID: 21245678
36 results